Trenchant partnered with Autolomous, integrating its digital solution into its CGT manufacturing platform, for faster production and lower costs.

Despite the powerful cancer-fighting capabilities of treatments based on CAR-T cells to fight a patient’s cancer, one key challenge is getting these treatments to more patients.

Amid concerns about mass deportation and a change in federal policy that allows immigration officers to visit schools, ...

Bengaluru’s Aecoz, owned by Dhanvita Sathyanand, Srinidhi Rajaram, and Bharath Sathyanand, is proving that sustainable ...

Celebs love health tech that promises to offer anti-ageing, speed up metabolism, and reduce inflammation so Bethan King ...

Looking for premium ice cream made with real ingredients? These 15 brands use fresh cream, organic fruits, fair-trade ...

The Skating Club of Boston lost two coaches, two young skaters and their two mothers in the deadly crash of American Airlines ...

He won an Emmy for his enthusiastic and sometimes acerbic analysis on sportscasts, but before that he made history as a ...

D2C business Wild Alaskan Company ships its seafood using bio-based foam insulation from TemperPack that is home and ...

Benchmark analysts have increased the price target for Belite Bio, Inc (NASDAQ:BLTE) shares to $79.00, up from the previous target of $57.00, while reiterating a Buy rating on the stock. The decision ...